Other
Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year 5 Through 10
CVS Health Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year 5 Through 10 increased by 21.5% to $5.71B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 29.0%, from $4.42B to $5.71B.
Analysis
StatementBalance Sheet Statement
SectionOther
First reportedQ1 2019
Last reportedQ1 2026May 6, 2026
Metric ID:
other_available_for_sale_securities_debt_maturities_afte_0f7586Historical Data
13 periods
| Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $5.13B | $5.03B | $4.98B | $4.63B | $4.41B | $4.28B | $4.59B | $4.42B | $4.83B | $4.42B | $4.53B | $4.7B | $5.71B |
| QoQ Change | — | -1.9% | -1.0% | -7.1% | -4.7% | -2.9% | +7.2% | -3.7% | +9.2% | -8.4% | +2.5% | +3.6% | +21.5% |
| YoY Change | — | — | — | -9.8% | -12.4% | -14.1% | -0.8% | +0.3% | +12.8% | -3.6% | +2.6% | -2.7% | +29.0% |
Range$4.28B – $5.71B
CAGR+3.6%
Avg YoY Growth+0.1%
Median YoY Growth-1.8%
Current Streak3 quarters growth
Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year 5 Through 10 at Other Companies
Frequently Asked Questions
- What is CVS Health's debt securities, available-for-sale, amortized cost, maturity, allocated and single maturity date, after year 5 through 10?
- CVS Health (CVS) reported debt securities, available-for-sale, amortized cost, maturity, allocated and single maturity date, after year 5 through 10 of $5.71B in Q1 2026.
- How has CVS Health's debt securities, available-for-sale, amortized cost, maturity, allocated and single maturity date, after year 5 through 10 changed year-over-year?
- CVS Health's debt securities, available-for-sale, amortized cost, maturity, allocated and single maturity date, after year 5 through 10 increased by 29.0% year-over-year, from $4.42B to $5.71B.